Phioanh L. Nghiemphu

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla et al. · Nature Medicine · 2019 · 1.3K citations

Neuro-oncology, Neoadjuvant Anti-pd-1 Immunotherapy, Tumor Immunology +14

Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma

Tim Cloughesy, Koji Yoshimoto, Phioanh L. Nghiemphu et al. · PLoS Medicine · 2008 · 585 citations · Full text

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

Albert Lai, Anh Tran, Phioanh L. Nghiemphu et al. · Journal of Clinical Oncology · 2010 · 451 citations · Full text

Evidence for Sequenced Molecular Evolution of <i>IDH1</i> Mutant Glioblastoma From a Distinct Cell of Origin

Albert Lai, Samir Kharbanda, Whitney B. Pope et al. · Journal of Clinical Oncology · 2011 · 438 citations · Full text

Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular Domain

Jeffrey C. Lee, Igor Vivanco, Rameen Beroukhim et al. · PLoS Medicine · 2006 · 362 citations · Full text